9-136893001-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_021138.4(TRAF2):​c.-28-5712C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.799 in 152,210 control chromosomes in the GnomAD database, including 48,761 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.80 ( 48761 hom., cov: 32)

Consequence

TRAF2
NM_021138.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.496

Publications

9 publications found
Variant links:
Genes affected
TRAF2 (HGNC:12032): (TNF receptor associated factor 2) The protein encoded by this gene is a member of the TNF receptor associated factor (TRAF) protein family. TRAF proteins associate with, and mediate the signal transduction from members of the TNF receptor superfamily. This protein directly interacts with TNF receptors, and forms a heterodimeric complex with TRAF1. This protein is required for TNF-alpha-mediated activation of MAPK8/JNK and NF-kappaB. The protein complex formed by this protein and TRAF1 interacts with the inhibitor-of-apoptosis proteins (IAPs), and functions as a mediator of the anti-apoptotic signals from TNF receptors. The interaction of this protein with TRADD, a TNF receptor associated apoptotic signal transducer, ensures the recruitment of IAPs for the direct inhibition of caspase activation. BIRC2/c-IAP1, an apoptosis inhibitor possessing ubiquitin ligase activity, can unbiquitinate and induce the degradation of this protein, and thus potentiate TNF-induced apoptosis. Multiple alternatively spliced transcript variants have been found for this gene, but the biological validity of only one transcript has been determined. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.847 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TRAF2NM_021138.4 linkc.-28-5712C>T intron_variant Intron 1 of 10 ENST00000247668.7 NP_066961.2 Q12933-1A0A024R8H5
TRAF2XM_011518976.4 linkc.-28-5712C>T intron_variant Intron 2 of 11 XP_011517278.1 Q12933-1A0A024R8H5
TRAF2XM_011518977.3 linkc.-28-5712C>T intron_variant Intron 1 of 10 XP_011517279.1 Q12933-1A0A024R8H5
TRAF2XM_047423829.1 linkc.-29+2459C>T intron_variant Intron 2 of 11 XP_047279785.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRAF2ENST00000247668.7 linkc.-28-5712C>T intron_variant Intron 1 of 10 1 NM_021138.4 ENSP00000247668.2 Q12933-1

Frequencies

GnomAD3 genomes
AF:
0.799
AC:
121468
AN:
152092
Hom.:
48738
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.855
Gnomad AMI
AF:
0.799
Gnomad AMR
AF:
0.669
Gnomad ASJ
AF:
0.787
Gnomad EAS
AF:
0.869
Gnomad SAS
AF:
0.834
Gnomad FIN
AF:
0.810
Gnomad MID
AF:
0.722
Gnomad NFE
AF:
0.785
Gnomad OTH
AF:
0.776
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.799
AC:
121547
AN:
152210
Hom.:
48761
Cov.:
32
AF XY:
0.799
AC XY:
59431
AN XY:
74418
show subpopulations
African (AFR)
AF:
0.855
AC:
35512
AN:
41544
American (AMR)
AF:
0.669
AC:
10215
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.787
AC:
2731
AN:
3470
East Asian (EAS)
AF:
0.869
AC:
4498
AN:
5178
South Asian (SAS)
AF:
0.832
AC:
4017
AN:
4826
European-Finnish (FIN)
AF:
0.810
AC:
8594
AN:
10606
Middle Eastern (MID)
AF:
0.721
AC:
212
AN:
294
European-Non Finnish (NFE)
AF:
0.785
AC:
53396
AN:
68002
Other (OTH)
AF:
0.779
AC:
1645
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1279
2559
3838
5118
6397
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
884
1768
2652
3536
4420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.781
Hom.:
20393
Bravo
AF:
0.788
Asia WGS
AF:
0.821
AC:
2857
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
2.6
DANN
Benign
0.77
PhyloP100
-0.50
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2811761; hg19: chr9-139787453; API